Arkolith/Insider Trading/HBIO/Form 4

Cote Jennifer

Chief Financial Officer, DirectorHARVARD BIOSCIENCE INC (HBIO) · full profile →Form 4 · filed Jan 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2023Tax withholding(F)3K$5.35$14K107K
Dec 29, 2023Tax withholding(F)3K$5.35$18K110K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-24-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML